HARBOURVEST PARTNERS LLC - PROTEOSTASIS THERAPEUTICS IN ownership

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$485,000
-19.7%
440,6270.0%0.18%
-31.2%
Q2 2020$604,000
+20.3%
440,6270.0%0.26%
+7.4%
Q1 2020$502,000
-50.0%
440,6270.0%0.24%
-41.5%
Q4 2019$1,005,000
+170.2%
440,6270.0%0.41%
+167.1%
Q3 2019$372,000
-56.7%
440,627
-50.0%
0.16%
-3.7%
Q2 2019$860,000
+55.0%
881,254
+100.0%
0.16%
-17.9%
Q1 2019$555,000
-61.1%
440,6270.0%0.20%
-71.0%
Q4 2018$1,428,000
+34.5%
440,6270.0%0.68%
-29.5%
Q3 2018$1,062,000
-13.6%
440,6270.0%0.96%
-38.1%
Q2 2018$1,229,000
-41.3%
440,6270.0%1.55%
-31.1%
Q1 2018$2,093,000
-18.5%
440,6270.0%2.25%
+8.8%
Q4 2017$2,569,000
+177.7%
440,6270.0%2.07%
+239.3%
Q3 2017$925,000
-55.1%
440,6270.0%0.61%
-31.3%
Q2 2017$2,062,000
-40.2%
440,6270.0%0.89%
-53.9%
Q1 2017$3,446,000440,6271.93%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders